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A randomized clinical trial of cognitive behavioral
therapy and interpersonal psychotherapy for panic
disorder with agoraphobia
S. P. F. Vos1*, M. J. H. Huibers1, L. Diels2 and A. Arntz1
1 Department of Clinical Psychological Science, Faculty of Neuroscience and Psychology, Maastricht University, The Netherlands
2 Regional Hospital AZ Vesalius, Tongeren, Belgium
Background. Interpersonal psychotherapy (IPT) seems to be as eﬀective as cognitive behavioral therapy (CBT) in the
treatment of major depression. Because the onset of panic attacks is often related to increased interpersonal life stress,
IPT has the potential to also treat panic disorder. To date, a preliminary open trial yielded promising results but there
have been no randomized controlled trials directly comparing CBT and IPT for panic disorder.
Method. This study aimed to directly compare the eﬀects of CBT versus IPT for the treatment of panic disorder with
agoraphobia. Ninety-one adult patients with a primary diagnosis of DSM-III or DSM-IV panic disorder with
agoraphobia were randomized. Primary outcomes were panic attack frequency and an idiosyncratic behavioral test.
Secondary outcomes were panic and agoraphobia severity, panic-related cognitions, interpersonal functioning and
general psychopathology. Measures were taken at 0, 3 and 4 months (baseline, end of treatment and follow-up).
Results. Intention-to-treat (ITT) analyses on the primary outcomes indicated superior eﬀects for CBT in treating
panic disorder with agoraphobia. Per-protocol analyses emphasized the diﬀerences between treatments and yielded
larger eﬀect sizes. Reductions in the secondary outcomes were equal for both treatments, except for agoraphobic
complaints and behavior and the credibility ratings of negative interpretations of bodily sensations, all of which
decreased more in CBT.
Conclusions. CBT is the preferred treatment for panic disorder with agoraphobia compared to IPT. Mechanisms of
change should be investigated further, along with long-term outcomes.
Received 6 January 2011 ; Revised 30 August 2011 ; Accepted 29 March 2012 ; First published online 30 April 2012
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Introduction
Panic disorder with agoraphobia can be eﬀectively
treated with cognitive behavioral therapy (CBT), an
empirically based treatment with central elements of
in vivo exposure and speciﬁc cognition challenging
(Clark, 1986 ; Barlow & Craske, 1994; Clark et al. 1994,
1997). In clinical settings, alternative forms of psycho-
therapy are also frequently used in the treatment of
panic disorder. There is, however, surprisingly little
systematic research on the eﬀectiveness of these
therapies, as most treatment studies for panic disorder
have focused primarily on CBT (Goisman et al. 1993).
There are indications that primary panic attacks
arise during times of increased interpersonal life
stress (Faravelli & Pallanti, 1989 ; Pollard et al. 1989).
Consequently, therapeutic approaches targeting the
interpersonal context of the patient have the potential
to be eﬀective treatments for panic disorder. Initial
studies in this area have yielded mixed results. Shear
et al. (1994) found a non-prescriptive treatment focus-
ing on interpersonal life stressors was as eﬀective as
CBT for the treatment of panic disorder. However,
the subsequently developed emotion focused therapy
(EFT; Shear & Weiner, 1997), which emphasizes in-
terpersonal conﬂicts as triggers for panic attacks, was
demonstrated to be inferior to CBT (Craske et al. 1995 ;
Shear et al. 2001).
Another approach focusing on the interpersonal
context of the patient is interpersonal psychotherapy
(IPT; Klerman et al. 1984). In relation to the above-
mentioned interpersonal approaches, IPT focuses on
the external interpersonal world instead of in-
trapersonal emotions and conﬂicts. IPT was originally
developed and subsequently proven to be successful
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as a treatment for major depression (Klerman et al.
1984 ; Elkin et al. 1989 ; Weismann et al. 2000 ; Luty et al.
2007). The eﬀectiveness of this approach has also been
demonstrated in bulimia nervosa (Fairburn et al. 1991 ;
Wilﬂey et al. 2002).
An open pilot study by Lipsitz et al. (2006) yielded
promising results for IPT as a treatment for panic dis-
order but more systematic research is required. The
present study is the ﬁrst to compare the eﬀectiveness
of CBT and IPT as treatments for panic disorder with
agoraphobia in a randomized clinical trial. We studied
CBT and IPT without adjacent pharmacological treat-
ment to have a clear indication of their relative eﬀec-
tiveness.
Method
Participants
Participants were recruited, assessed and treated at
the Academic Community Mental Health Center in
Maastricht between 1996 and 2005. Diagnostic status
was determined with the Structured Clinical Interview
for DSM-III-R and DSM-IV Axis I disorders (SCID-I ;
First et al. 1990, 1996). Inclusion criteria consisted of a
primary diagnosis of panic disorder with moderate to
severe agoraphobia and age 18–60 years. Exclusion
criteria included: co-morbid psychosis or bipolar
disorder, alcohol or drug dependence, use of psycho-
active drugs, an intelligence quotient (IQ) <80, insuf-
ﬁcient understanding of the Dutch language, formal
CBT or IPT treatment for the same complaint in the
previous year, cardiovascular or respiratory disease,
or epilepsy. Patients who were able to stop the use of
psycho-active medication were included after 2 weeks
of non-usage. The study was approved by the in-
stitute’s ethics board, and all participants provided
written informed consent. Of the 268 patients with a
primary diagnosis of panic disorder with agoraphobia
screened for participation, 91 (34.0%) were initially
included in the study (see online Supplementary
Fig. S1 for the subject ﬂow chart and Table 1 for subject
characteristics at baseline).
Interventions
IPT treatment was based on standard IPT for de-
pression. Twelve 1-h individual weekly sessions were
subdivided into three main phases : ﬁrst, providing
information, placing panic disorder into the medical
Table 1. Baseline characteristics of study participants
Characteristics IPT group (n=43) CBT group (n=48)
Age (years), mean (S.D.) 36.74 (11.07) 33.04 (10.13)
Gender (male/female), n (%) 11/32 (25.60/74.40) 10/38 (20.80/79.20)
Education (1=low, 7=high)a,
mean (S.D.)
2.61 (1.38) 2.88 (1.42)
Employment status, n (%)
Housewife 16 (37.21) 10 (20.83)
Student 5 (11.63) 4 (8.33)
Full-time job 6 (13.95) 7 (14.58)
Part-time job 10 (23.26) 13 (27.08)
Disability 13 (30.23) 16 (33.33)
Partial disability 0 (0.00) 2 (4.17)
Unemployed 4 (9.30) 5 (10.42)
Other 4 (9.30) 2 (4.17)
Medication at screeningb, n (%)
No use of medication 30 (69.77) 29 (60.43)
Tranquillizers 5 (11.63) 8 (16.6)
Sleep medication 2 (4.65) 1 (2.08)
Antidepressants 4 (9.30) 6 (12.50)
Others 5 (11.63) 9 (18.75)
Duration of complaint in months,
mean (S.D.)
57.14 (71.50) 57.28 (75.59)
Received previous treatment, n (%) 17 (39.54) 19 (39.58)
No. of Axis I diagnoses, mean (S.D.) 2.51 (1.24) 2.44 (1.27)
IPT, Interpersonal psychotherapy ; CBT, cognitive behavioral therapy ; S.D.,
standard deviation.
a None of the participants completed a university education.
bMedication was tapered 2 weeks before baseline assessment.
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model, determining treatment focus (role conﬂict,
transition, grief or skills deﬁcit) ; second, exploring the
interpersonal problem area and considering options
for improvement ; and third, preparing for treatment
termination (a more detailed description of IPT treat-
ment is available online in Supplementary Table S1).
CBT treatment was based on the models of Beck
et al. (1985), Clark (1986) and Barlow (1988) and com-
bined cognitive therapy with in vivo and interoceptive
exposure to reduce chronic (situational) avoidance.
Treatment also consisted of 12 1-h individual weekly
sessions that were highly structured compared to IPT.
Panic attacks were proposed to be the result of mis-
interpreted bodily sensations. These misinterpret-
ations were subsequently challenged with a range of
cognitive and behavioral techniques. Agoraphobic
avoidance was addressed with hierarchical assign-
ments of exposure in vivo.
Design and procedures
Patients were randomly assigned to CBT (n=48) or
IPT (n=43). Randomization occurred at the therapists’
meetings after inclusion and baseline assessment. A
non-treating therapist assigned the two conditions
to heads or tails and a second non-treating therapist
tossed the coin visible to all therapists present.
Assessments took place at baseline (0 months), im-
mediately after treatment (3 months) and at 4 months.
Panic diaries were collected weekly during therapy
and the 1-month follow-up period.
Treatment integrity
Protocol adherence was assessed with an adapted
version of the Collaborative Study Psychotherapy
Rating Scale – Form 6 (CSPRS-6 ; Hollon et al. 1988,
1994). The CSPRS-6 was originally used as an adher-
ence check for treatment protocols (IPT, CBT and
clinical management) in the Treatment of Depression
Collaborative Research Program (Elkin et al. 1985). To
use the CSPRS-6 in the present study, adjustments
were made to the original 96 items: non-relevant items
were deleted (i.e. items related to clinical manage-
ment) and some items related to CBT were adjusted
because CBT treatment for panic diﬀers from CBT
treatment for depression (Beck et al. 1979). The items
related to IPT and the non-modality speciﬁc scales (i.e.
facilitative conditions and explicit directiveness) were
changed slightly because the applied IPT remained
predominantly similar to IPT for depression (Klerman
et al. 1984).
Two randomly selected audiotaped sessions of a
therapist–subject pair were scored by two independent
raters who were blind to condition. Raters received
40 h of training prior to scoring.
Treatment credibility
At the end of the ﬁrst therapy session, patients com-
pleted three treatment credibility self-report items on
nine-point Likert scales, assessing the credibility of
the treatment rationale and the patients’ expectations
regarding treatment (Borkovec &Nau, 1972; Devilly &
Borkovec, 2000). Scores were concealed from the
therapists.
Therapists
Over 9 years, a total of 17 therapists participated in the
present study. The initial therapist group attended a
2-day workshop of IPT given by J. C. Markowitz and
CBT given by P. Salkovskis. New therapists entering
the protocol were trained and assessed by these initial
therapists. To control for individual therapist charac-
teristics, therapists provided care in both treat-
ment modalities. Therapists were masters-prepared or
higher-level clinicians with a range of experience in
delivering CBT and IPT (1–10 years) prior to this
study.
Sample size
Based on previous studies we estimated that CBT
treatment would have an eﬀect size of 1 (Clark et al.
1994). If IPT had only non-speciﬁc (placebo) eﬀects, we
expected its eﬀect size to be approximately 0.33. To
detect the diﬀerence in eﬀect size of 0.67 at a two-sided
signiﬁcance level of 5% and a power of 80%, a sample
size of 36 patients per group (in total 72 patients) was
needed. To account for attrition, we increased the
sample size to 91 patients.
Primary outcomes
Panic attack frequency
Panic diaries were completed on a daily basis, report-
ing each panic attack and associated experienced
symptoms. Only attacks meeting DSM-IV criteria were
taken into account.
Behavioral test
Three behaviors of increasing level of diﬃculty rel-
evant to the patient but usually avoided were speciﬁed
in cooperation with the therapist before random-
ization. Together, the therapist and patient explored
situations that the patient usually avoided, and
ranked them. From the top quartile, three situations
were selected to represent severe avoidance. Safety
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behaviors were explored and prohibited in the in-
structions given to the patient. The therapist sub-
sequently discussed the assigned task with peers and
the investigator, and adapted the instructions as nee-
ded to increase feasibility. Examples of behavioral si-
tuations are : (1) taking the bus alone for 30 min at a
busy time of the day, (2) taking a walk alone through
the city center for 20 min without bringing along a
bottle of water, and (3) taking the stairs to the ﬁfth
ﬂoor of a building and walking at a normal pace
(so that the patient’s heart would pound faster).
Assessment by a research assistant took place at 0 and
4 months. Situations had to be executed to a normally
tolerable degree without force, and it was stated
speciﬁcally that execution or completion was not
obligatory. Degree of performance (0%=no perform-
ance to 100%=complete performance) and experi-
enced fear (0=totally at ease to 8=totally in panic)
were rated by the patient and research assistant.
Secondary outcomes
Panic and agoraphobia severity
The Body Sensation Questionnaire (BSQ; Chambless
et al. 1984 ; Bouman, 1998) assesses fear of bodily sen-
sations on three subscales : disposition, frequency and
state. The Fear of Fear (FOF) questionnaire (Van den
Hout et al. 1987) measures fear of bodily sensations
experienced during a panic attack. The Fear Ques-
tionnaire (FQ; Marks & Mathews, 1979) assesses the
amount of fear and avoidance in agoraphobic situ-
ations, and has idiosyncratic ratings.
Panic-related cognitions
These were assessed with the Agoraphobic Cognition
Questionnaire (ACQ; Chambless et al. 1984) and the
Anxiety Sensitivity Index (ASI ; Reiss et al. 1986). The
ACQ is a checklist of 14 thoughts possibly experienced
during a state of anxiety, and the ASI evaluates the
tendency to respond fearfully to anxiety-related
symptoms.
General psychopathology
The 90-item Symptom Checklist (SCL-90 ; Derogatis
et al. 1973 ; Arrindell & Ettema, 1981) assesses recently
experienced psychological and physical complaints on
eight subscales : fear, agoraphobia, depression, so-
matic complaints, mistrust and interpersonal sensi-
tivity, inadequacy of thought and action, sleeping
problems and anger/hostility. The items are rated on a
ﬁve-point Likert scale (total score of the Dutch version
ranges from 90 to 450). State and trait types of anxiety
were assessed with the State–Trait Anxiety Inventory
(STAI ; Spielberger et al. 1983). Both instruments have
good reliability and validity (Metzger, 1976 ; Evers
et al. 2000).
IPT and CBT speciﬁc measures
Cognitive beliefs
The 14-item Body Sensation Interpretation Question-
naire (BSIQ-14 ; Clark et al. 1997) assesses interpret-
ations of ambiguous events, including a range of bodily
sensations. Additionally, the patient and therapist
formulated 1–3 idiosyncratic catastrophic interpret-
ations (Arntz, 2002) of feared bodily sensations before
randomization. Their credibility at the moment of as-
sessment and during a panic attack (retrospectively)
was rated at each assessment using a 0–100-mm visual
analogue scale (VAS).
Interpersonal functioning
The Inventory of Interpersonal Problems (IIP ;
Horowitz et al. 1988), a 127-item self-report scale, as-
sesses interpersonal functioning. Higher scores indi-
cate poorer functioning.
Data reduction and analysis
Statistical analyses were performed using SPSS ver-
sion 15.0 for Windows (SPSS Inc., USA) and the stat-
istical package R (R Development Core Team, 2009).
Because of missing data, sample size varies to some
extent among outcome measures. Intermittent missing
data were imputed by the mean value of the previous
and subsequent time point. Other missing data were
not imputed. Intention-to-treat (ITT) analyses were
conducted based on the last observation carried for-
ward (LOCF, n=91) method. Additional per-protocol
analyses were carried out for the primary outcome
measures with therapy completers (patients who re-
ceived the full 12-session treatment and completed the
study measurements, n=67) and study completers
(therapy completers n=67, plus patients who com-
pleted the study measurements but dropped out, at
any given point, during treatment n=3 ; total study
completers n=70).
Primary measures
Panic attack frequency
Blocks were created from the panic diary data by
averaging the number of panic attacks during baseline
and each subsequent 3 weeks of therapy until the end
of the study at 4 months. Log transformations were
executed to reduce the extreme skewness of the data ;
however, the data still violated the assumptions for
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parametric testing and were consequently analyzed
with robust statistical methods (Wilcox, 2005). Within-
condition eﬀects were investigated with a percentile
bootstrap method for estimating signiﬁcance for one-
sample data on the linear trend from 0 to 4 months. We
tested therapy eﬀects with the Wilcox ANCOVA on
20% trimmed means with a percentile bootstrap
method, with the linear trend from 0 to 4 months as
the dependent variable and baseline as the covariate.
Because of their avoidant behavior, many patients
with panic disorder with agoraphobia experience no
panic attacks at the time they come into therapy (no
experienced panic attack during the baseline period of
3 weeks : CBT: 20.9%; IPT: 26.8%). Consequently, a
ﬂoor eﬀect is inherent to the panic attack frequency
measure.
Behavioral test
A principal component analysis (PCA; eigenvalues
and explained variance at 0 months 3.72 and 93% re-
spectively, and at 4 months 3.66 and 92% respectively)
indicated that the behavioral test scores loaded on a
single factor, so a composite measure was created by
averaging patients’ and research assistants’ perform-
ance and fear ratings (transformed fear 0=maximum
to 100=minimum). The reliability of the composite
measure was suﬃcient (a=0.75). The data violated the
assumptions for parametric testing and were conse-
quently analyzed with robust statistical methods
(Wilcox, 2005). To investigate within-condition eﬀects,
a percentile bootstrap method for estimating signiﬁ-
cance for one-sample data was used on diﬀerence
scores. The therapy eﬀect was tested with the Wilcox
ANCOVA on 20% trimmed means with a percentile
bootstrap method, with the linear trend from 0 to 4
months as the dependent variable and the baseline
rank scores as covariate.
Secondary measures
For the secondary measures, only ITT analyses were
executed. Based on a PCA, three composite measures
(agoraphobia, general psychopathology and anxiety-
related feelings and cognitions) were created from
the remaining set of secondary outcomes to reduce
experiment-wise error and increase power (Hollon
et al. 1992 ; Clark et al. 1994 ; an outline of the subscales
and composite measures is available online in
Supplementary Table S2). Scores on the main 23 sec-
ondary (sub)scales were transformed for each partici-
pant into z scores (mean and standard deviation
were computed for each measure across all measure-
ment times). Composite measures were created by
averaging z scores of the relevant (sub)scales per
measurement time.
Data for the agoraphobia composite measure were
transformed by a square root transformation. The
general psychopathology and anxiety-related feelings
and cognitions composite measures remained non-
normally distributed after transformation. Within-
condition eﬀects were investigated with a one-sample
t test or a percentile bootstrap method for estimating
the signiﬁcance for one-sample data on diﬀerence
scores. Between-condition analyses were conducted
on the linear trend from 0 to 4 months by ANCOVA or
Wilcox ANCOVA on 20% trimmed means with a
percentile bootstrap method, using therapy modality
as the between-subjects factor and baseline measure-
ment (0 months) as the covariate.
IPT and CBT speciﬁc measures
IPT and CBT speciﬁc measures were not intended as
clinical outcome measures ; therefore, only therapy
completers’ analyses were conducted. For the BSIQ-14,
only items relating to bodily sensations and the belief
scores of their negative interpretations were taken into
account, as previous ﬁndings indicate that the changes
in belief scores are more sensitive for treatment com-
pared to ranking scores (Clark et al. 1997). A PCA in-
cluding pre–post-measure diﬀerence scores of the
BSIQ-14 belief scores and the idiosyncratic mis-
interpretations showed that these measures loaded on
a single factor (eigenvalue and explained variance :
1.736, 58%). Subsequently these scores were trans-
formed for each participant into z scores (mean and
standard deviation were computed for each measure
across all measurement times) and a composite
measure of beliefs was created by averaging the z
scores for each measurement time.
The data of the IIP and the Beliefs composite
measure violated the assumptions for parametric
testing, apart from the ANCOVA on the IIP, and were
consequently analyzed with robust statistical methods
(Wilcox, 2005). To investigate within-condition eﬀects,
a percentile bootstrap method for estimating signiﬁ-
cance for one-sample data was used for diﬀerence
scores. The therapy eﬀect was tested on the linear
trend from 0 to 4 months by ANCOVA or by Wilcox
ANCOVA on 20% trimmed means with a percentile
bootstrap method and the baseline measurement
(0 months) as covariate.
Eﬀect sizes and reliable change
Improvement eﬀect sizes were determined for all
outcome measures and all time points according to
Cohen’s d statistic (Cohen, 1988) calculated from the
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one-sample t statistic (if necessary, estimated from
the p value) of the diﬀerence scores. The between-
condition eﬀect sizes were also determined according
to Cohen’s d and calculated from the ANCOVA
t statistic (if necessary, estimated from the p value).
The percentage of reliably changed patients was
determined for the primary outcome measures
according to the method of Jacobson & Truax (1991) :
reliable change index (RC)=(x2 – x1)/Sdiﬀ, where
Sdiﬀ=
p
[2(SE)
2] and SE=s1
p
(1 – rxx). An RC value
>1.96 indicates an actual change at a signiﬁcance level
of p<0.05.
Results
Pretest diﬀerences
Diﬀerences on pretreatment variables including age,
sex, educational level, duration of complaints, medi-
cation use, pretest panic frequency, pretest behavioral
composite score and pretest (composite) questionnaire
scores were non-signiﬁcant and clinically non-relevant
between the two groups (Table 1).
Dropouts
Nine patients (21%) dropped out of IPT before
the 12th session and 15 (31%) dropped out of CBT
[x2 (1 ; n=91)=1.24, p=0.27]. The reasons for therapy
termination for IPT were: the patient refused con-
tinuation because they felt that another problem was
more urgent or prominent to treat, which led to an-
other treatment indication (n=2), no show and not
traceable (n=4), complaint improvement (n=1),
medication use (n=1) and referred because of infatu-
ation with the therapist (n=1). CBT termination
reasons included: pregnancy (n=1), lack of time
(n=2), complaint improvement (n=1), no show and
not traceable (n=3), crisis (n=4), the patient refused
continuation because they felt that another problem
was more urgent or prominent to treat, which led to
another treatment indication (n=2) and medication
use (n=2) (subject ﬂow chart available online).
Table 2. LOCF mean scores (S.E.) for primary and secondary outcome measures (20% trimmed means)
Outcome
CBT IPT
ANCOVA
linear trend : p ES(t)mean S.E.
Time
eﬀect : p ES (t)mean S.E.
Time
eﬀect : p ES
Panic attack frequency (log transformed)
0 months 0.82 0.12 0.90 0.18
3 months 0.25 0.10 <0.001 0.75 0.33 0.17 <0.001 0.52
4 months 0.28 0.10 <0.001 0.74 0.35 0.16 <0.001 0.51 0.042 0.45
Behavioral composite measure
0 months 26.66 4.05 36.42 4.56
4 months 47.82 5.06 <0.001 0.55 46.28 5.16 0.123 0.23 0.047 0.44
Agoraphobia composite measure
0 months 0.43 0.11 0.33 0.10
3 months x0.31 0.12 <0.001 1.00 x0.21 0.12 <0.001 0.74
4 months x0.39 0.13 <0.001 1.05 x0.27 0.12 <0.001 0.58 0.006 0.60
General psych. composite measure
0 months 0.15 0.15 0.14 0.14
3 months x0.18 0.16 <0.001 0.75 x0.06 0.20 0.003 0.48
4 months x0.19 0.23 <0.001 0.60 x0.13 0.24 0.001 0.53 0.103 0.35
Anxiety feelings and cognitions composite measure
0 months 0.33 0.10 0.31 0.12
3 months x0.21 0.12 <0.001 >0.77a x0.05 0.13 <0.001 0.80
4 months x0.27 0.12 <0.001 >0.78a x0.09 0.14 <0.001 0.75 0.393 0.18
LOCF, Last observation carried forward ; CBT, cognitive behavioral therapy ; IPT, interpersonal psychotherapy ;
S.E., standard error ; ES, eﬀect size (Cohen’s d).
a The ES is an estimate of the minimum size of the eﬀect. The ES was calculated with the p value and, in these cases, the p value
was 0 and contained, at the maximum number of bootstraps, no value other than 0 beyond the decimal point (e.g. 0.00000).
Consequently the p value was set at<1/no. of bootstraps (e.g.<1/700.000 or<0.0000014) so as to be able to calculate a
minimal ES.
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Treatment integrity
Inter-rater reliability and internal consistency of the
treatment integrity ratings were good to very good:
CBT scale (0.91, 0.84), IPT scale (0.90, 0.91), facilitative
conditions (FC) scale (0.75, 0.81), and explicit direc-
tiveness (ED) scale (0.58, 0.48). Predictive validity of
the adapted CSPRS-6 was excellent ; 76 out of 77 CBT
tapes were classiﬁed correctly as CBT sessions and 58
out of 60 IPT sessions were classiﬁed correctly as IPT
sessions by a discriminant analysis with the CSPRS-6
CBT and IPT subscales as independent variables.
(means, S.D. and independent-samples t tests of the
subscales are available online in Supplementary
Table S3).
Treatment credibility
The internal consistency of the scale was suﬃcient
(a=0.83). Mann–Whitney tests revealed no signiﬁcant
diﬀerence in sum scores between the two conditions
(U=599.5, p=0.955), indicating equal credibility of
CBT (mean=1389) and IPT (mean=1095) treatment
rationales.
Primary outcome measures
Panic attack frequency (n=87)
The linear trend of panic attack frequency deviated
signiﬁcantly from zero in both treatment modalities.
Descriptive data, p values and eﬀect sizes of all out-
come measures are presented in Table 2. The decrease
was signiﬁcantly larger for CBT than for IPT (see Fig. 1
for the linear trend of panic attack frequency).
Behavioral composite measure (n=85)
Achievements improved signiﬁcantly for CBT but not
for IPT. There was signiﬁcantly more improvement in
recipients of CBT compared to IPT (see Fig. 2 for the
linear trend of the behavioral composite measure).
Secondary outcome measures
Scores on the agoraphobic, general psychopathology
and anxiety cognitions and feelings composite meas-
ures decreased signiﬁcantly in both treatment modal-
ities (n=91). Decrease of scores on the agoraphobic
composite measure was signiﬁcantly larger for CBT
than IPT. For the other two composite measures
there were no signiﬁcant diﬀerences in the linear trend
between the two conditions.
IPT and CBT speciﬁc measures
IIP (n=57)
Scores decreased signiﬁcantly for CBT from 0 to 3 and
4 months but no signiﬁcant decrease occurred for IPT.
There was a greater signiﬁcant linear trend decrease in
CBT (Table 3).
Belief composite measure (n=60)
Scores decreased signiﬁcantly for CBT from 0 to 3 and
4 months and from 0 to 4 months for IPT. The decrease
was signiﬁcantly larger for CBT than for IPT (Table 3).
Reliable and clinically signiﬁcant change
Panic attack frequency
Percentages of panic-free patients, reliable change and
their combination at 3 and 4 months are presented in
Table 4. Logistic regression analyses with panic attack
absence (yes/no) at 3 or 4 months as the dependent
variable, baseline panic attack frequency as covariate
and condition as independent variable showed no
signiﬁcant condition eﬀects.
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Behavioral composite measure
Reliable change percentages are displayed in Table 4.
Logistic regression with reliable change (yes/no) at 4
months as the dependent variable, baseline measure-
ment as the covariate and condition as the indepen-
dent variable showed a signiﬁcant condition eﬀect in
the direction of CBT.
Per-protocol analyses
The results of the per-protocol analyses for the number
of panic attacks diﬀered from the ITT analyses as
the within-condition eﬀect sizes (ES) in the CBT con-
dition became larger for both the study and
therapy completers (n=70, 67) (>0.98, >1.03). The
between-condition diﬀerence increased for both the
study and therapy completers (p<0.001, ES=0.63 ;
p<0.001, ES=0.68).
For the idiosyncratic behavioral test, the eﬀect
sizes within the CBT condition became larger for
both the study and therapy completers (n=59, 57)
(4 months : 0.85, 0.86). The condition eﬀect also became
larger for both study and therapy completers
(p=0.005, ES=0.77 ; p=0.002, ES=0.88).
Adverse events
No adverse events were noted for either CBT or IPT
treatment conditions.
Table 3. Completers’ mean scores (S.E.) for condition-speciﬁc measures (20% trimmed means)
Outcome
CBT IPT
ANCOVA
linear trend : p ES(t)mean S.E.
Time
eﬀect : p ES (t)mean S.E.
Time
eﬀect : p ES
IIP
0 months 1.23 0.11 1.26 0.10
3 months 0.88 0.10 <0.001 0.82 1.04 0.14 0.26 0.21
4 months 0.79 0.12 <0.001 1.18 1.08 0.15 0.60 0.10 0.041 0.56
Beliefs composite measure
0 months 0.23 0.08 0.34 0.19
3 months x0.35 0.12 0.005 0.49 0.25 0.18 0.91 0.02
4 months x0.84 0.12 <0.001 >0.91a 0.01 0.16 <0.001 0.65 <0.001 >1.08a
CBT, Cognitive behavioral therapy ; IPT, interpersonal psychotherapy ; IIP, Inventory of Interpersonal Problems ;
S.E., standard error ; ES, eﬀect size.
a The ES is an estimate of the minimum size of the eﬀect. The ES was calculated with the p value and, in these cases, the
p value was 0 and contained, at the maximum number of bootstraps, no value other than 0 beyond the decimal point
(e.g. 0.00000). Consequently the p value was set at<1/no. of bootstraps (e.g.<1/700.000 or<0.0000014) so as to be able to
calculate a minimal ES.
Table 4. Primary outcome measures : absence of panic attack (PA) and reliable change (RC) at 3 and 4 months (LOCF)
CBT IPT Logistic regression
3 months 4 months 3 months 4 months 3 months 4 months
Panic attack frequency (%)
PA=0 52.1 47.9 53.5 53.5 b=x0.559, p=0.281 b=x0.365, p=0.497
RC 43.5 43.5 36.6 39.0 b=x0.421, p=0.373 b=x0.322, p=0.499
PA=0+RC 28.3 26.1 24.4 29.3 b=x0.211, p=0.668 b=0.150, p=0.754
Behavioral composite measurea (%)
RC x 35.6 x 15.0 x b=x1.066, p=0.05
LOCF, Last observation carried forward ; CBT, cognitive behavioral therapy ; IPT, interpersonal psychotherapy.
a For the behavioral composite measure no clinically signiﬁcant change was calculated because no norm data are available for
this measure and we regard the absence of behavioral fear and avoidance or a change of at least 2 S.D. from the pretreatment
mean too strict a criterion.
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Discussion
Main ﬁndings
This randomized trial compared CBT and IPT as
treatments for panic disorder with agoraphobia. Only
medication-free patients were included to obtain a
clear comparison of the two psychological treatments.
Independent raters gave high treatment adherence
scores to both treatments (Hill & O’Grady, 1992), in-
dicating that the treatments were given as intended.
On the two primary outcome measures, the results
indicate the superiority of CBT over IPT. Agoraphobic
avoidance and fear assessed with an idiosyncratic be-
havior test, in addition to panic attacks, improved
more after 12 sessions of CBT than after 12 sessions of
IPT treatment. These results held for all tests (ITT
analyses, study completers and therapy completers).
There was no diﬀerence between CBT and IPT in per-
centages of dropouts. Regarding the secondary out-
come measures, the results from the self-reported
agoraphobic symptoms are in line with the ﬁndings on
the behavioral test. The decrease of self-reported
agoraphobic problems was stronger in CBT than in
IPT at 3 and 4 months. Although not reﬂected in the
behavioral test, subjects within the IPT condition re-
ported a signiﬁcant decrease in agoraphobic behavior
at all assessment times. However, the decrease was
more prominent for CBT than IPT. General psycho-
pathology was reduced in line with previous research
(Fairburn et al. 1991 ; Wilﬂey et al. 2002) and was
similar for both treatment conditions. CBT was su-
perior in reducing the beliefs composite measure, and
interpersonal problems only reduced signiﬁcantly in
CBT.
Interpretations and methodological considerations
The eﬀect sizes in the present study were medium
to large, suggesting clinically meaningful diﬀerences
in addition to statistically signiﬁcant diﬀerences
(Norman et al. 2003). We conducted the present trial in
routine clinical practice, at an academic mental health
center. One obvious reason for the loss of patients
before randomization was the requirement that medi-
cation should be tapered: 32 patients refused or felt
unable to fulﬁll this requirement. We applied no strict
criteria in the sampling procedure concerning the
presence or absence of panic attacks, and consequently
a large number of the participating patients were
mainly agoraphobic and did not experience (many)
panic attacks. This obviously limits the attainable ef-
fect size of therapy on panic attack frequency, which is
indeed reﬂected in the eﬀect sizes obtained in our
study.
The trial was conducted over a period of 9 years
with the participation of 17 therapists. These thera-
pists had various levels of experience and many were
novice therapists. Most participating therapists were
CBT orientated and therefore might have had diﬃ-
culty applying IPT for panic disorder with agora-
phobia. However, the treatment adherence ratings
were good and the therapists generally experienced no
diﬃculty in ﬁnding an IPT focus with their patients.
A possible criticism of this study is that the applied
IPT protocol is not substantially diﬀerent from the IPT
protocol for depression. The only adaptation we made
was to focus more on future events instead of past
events, which made IPT highly acceptable for the
patients and helped to ﬁnd a treatment focus.
Contrary to CBT, IPT is a treatment not directly
focused on the complaint but more on the circum-
stances surrounding the complaint. Therefore, the IPT
protocol has a theoretically broader application than
merely for the treatment of depression, and conse-
quently does not require further adaptation for use in
panic disorder interventions.
The absence of change in interpersonal functioning
in the IPT condition, as measured with the IIP, and
the relatively small eﬀect sizes in the IPT condition
suggest that the signiﬁcant improvement of panic
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Fig. 2. (a) Trimmed means of behavioral composite measure [last observation carried forward (LOCF)]. (b) Behavioral composite
measure trimmed means (LOCF) per quintile (divided into ﬁfths), determined by the Wilcox ANCOVA design points.
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symptoms in IPT are not caused by the treatments’
theoretically assumed mechanism of change. This
suggests that common therapeutic factors or even a
placebo attention eﬀect could be responsible for the
observed improvement. However, because CBT led to
a reduction of interpersonal problems (although CBT
does not address interpersonal problems), this sug-
gests that it is possible that, when overcoming a panic
disorder and associated agoraphobic avoidance, in-
terpersonal problems reduce accordingly. However,
based on the present results we cannot draw distinct
conclusions regarding the possible mediating eﬀects of
changes in cognitive beliefs and interpersonal func-
tioning between CBT and IPT on changes in panic
disorder symptoms. These relationships should be
investigated in further detail to elaborate on the
condition-speciﬁc mechanisms of change.
Another issue of relevance in the context of the
larger ongoing debate on the eﬀective elements in
psychological treatment is the structure of the treat-
ments. CBT is a highly structured and directive treat-
ment whereas IPT is less structured and less directive
(e.g. no homework assignments). To what extent this
diﬀerence in structure contributes to the diﬀerence in
eﬀectiveness, apart from the speciﬁc content of the
treatments (e.g. changing cognitions versus improving
interpersonal functioning), is also a question that re-
mains unanswered.
Finally, it would be interesting to conduct longer
follow-up assessments to investigate the long-term
eﬀects of IPT and CBT. Ethical restrictions prevented
us from studying clear long-term eﬀects of IPT and
CBT, as the center was obliged to oﬀer further treat-
ment after the 4-month assessment.
Conclusions
We are the ﬁrst to study IPT as a treatment for panic
disorder with agoraphobia and compare this treat-
ment with CBT in a randomized trial. The results
suggest that CBT is superior as a treatment for panic
disorder with agoraphobia. Future studies should in-
dicate to what degree exposure in vivo is the essential
treatment ingredient if there is an agoraphobia com-
plicating the panic disorder. For panic disorder with
agoraphobia, CBT seems the psychological treatment
of choice (see also Craske et al. 1995 ; Shear et al. 2001).
The results of the present study are convincingly in
favor of CBT.
Supplementary material
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